Foundation for Sarcoidosis Research Awards Dr. Christen Vagts, University of Illinois Hospital and Clinic, Fellowship Grant for 2023–2025
July 25, 2023 17:03 ET
|
Foundation for Sarcoidosis Research
CHICAGO, July 25, 2023 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is pleased to announce that the FSR Sarcoidosis Research Fellowship for 2023-2025 is being awarded to Dr....
The U.S. Food and Drug Administration Gives the Green Light to Molecure’s Flagship Program – Phase II Clinical Testing of OATD-01 is Ready for Launch
July 24, 2023 09:00 ET
|
Molecure
Press release The U.S. Food and Drug Administration Gives the Green Light to Molecure’s Flagship Program – Phase II Clinical Testing of OATD-01 is Ready for Launch Molecure can proceed with clinical...
Foundation for Sarcoidosis Research Appoints Two New Members, Calvin Harris Jr., CPA and Joel D. Rosen, Esq., to Board of Directors
July 13, 2023 14:39 ET
|
Foundation for Sarcoidosis Research
CHICAGO, July 13, 2023 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is pleased to announce the appointment of Calvin Harris Jr., CPA and Joel D. Rosen, Esq. to the FSR Board of...
Foundation for Sarcoidosis Research Releases White Paper and Hosts Congressional Briefing on Advancing Clinical Trial Equity for Black Patients with Sarcoidosis
May 22, 2023 10:15 ET
|
Foundation for Sarcoidosis Research
CHICAGO, May 22, 2023 (GLOBE NEWSWIRE) -- Foundation for Sarcoidosis Research (FSR), the leading international organization dedicated to elevating research, raising awareness and providing support...
AI Therapeutics Announces Poster Presentation at the 2023 American Thoracic Society International Conference
May 09, 2023 10:38 ET
|
AI Therapeutics, Inc.
GUILFORD, Conn., May 09, 2023 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today Dr Antje Prasse...
Foundation for Sarcoidosis Research launches the Stand Up for Sarc National Campaign for April’s Awareness Month for the 175,000+ People in the U.S. Living with Sarcoidosis
March 30, 2023 11:43 ET
|
Foundation for Sarcoidosis Research
CHICAGO, March 30, 2023 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is proud to launch the Stand Up for Sarc Campaign this April as part of National Sarcoidosis Awareness...
aTyr Pharma Announces First Major Review Article for Efzofitimod Published in the Journal Sarcoidosis, Vasculitis and Diffuse Lung Diseases
March 30, 2023 08:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, March 30, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary...
Foundation for Sarcoidosis Research (FSR) Inaugural Sarcoidosis Crystal Awards Gala to honor actor, Jeryl Prescott Gallien, Dr. George Mensah, Director of The Center for Translation Research and Implementation Science from the NIH, news anchor and podcaster, John Carlin, and world-renowned sarcoidosis researcher, Dr. Marjolein Drent
February 28, 2023 14:56 ET
|
Foundation for Sarcoidosis Research
CHICAGO, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR), the leading international nonprofit organization dedicated to finding a cure and improving care for...
aTyr Pharma Presents Clinical Data for Efzofitimod (ATYR1923) at the American Thoracic Society 2022 International Conference
May 17, 2022 08:00 ET
|
aTyr Pharma, Inc.
Results from Phase 1b/2a study of efzofitimod in pulmonary sarcoidosis patients demonstrate dose-dependent improvements in key physiologic and quality of life measures in context of a steroid taper. ...
aTyr Pharma Announces FDA Orphan Drug Designation for ATYR1923 for Treatment of Sarcoidosis
January 06, 2022 08:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotherapeutics company engaged in the discovery and development of innovative medicines based on...